Company news
Dx & Vx Co., Ltd. (KRX:180400) news
Dx & Vx Co., Ltd. news releases on 6ix. Latest, Sep 26, 2025: COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients
Press releases & updates
COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients
September 26, 2025
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
August 18, 2025
Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company
July 30, 2025
Dx&Vx Accelerates Development of Universal COVID-19 Vaccine
May 29, 2025